TGOD.TO stock is the TSX’s most active pre-market name with 19,704,275 shares trading and a last print of C$0.17. The Green Organic Dutchman Holdings Ltd. (TGOD.TO) opened at C$0.26 and is running a wide intraday range between C$0.165 and C$0.22. Average daily volume is 1,585,835, making today’s activity roughly 12.43x the norm. Pre-market interest is concentrated in speculative flows and short covering. We examine fundamentals, technicals, and Meyka AI forecasts to frame near-term scenarios for TGOD.TO stock on the TSX in Canada.
TGOD.TO stock live trading snapshot
TGOD.TO is trading at C$0.17 in pre-market on 31 Mar 2026 with 19,704,275 shares traded so far. The day range is C$0.165–C$0.22 and the 52-week range is C$0.165–C$0.65. Relative volume is 12.43, signaling outsized activity versus the 1,585,835 average volume.
Fundamentals and valuation for The Green Organic Dutchman (TGOD.TO stock)
The Green Organic Dutchman reports trailing EPS of -0.23 and a negative P/E of -0.74, reflecting losses. Key ratios include a price-to-book of 0.45, current ratio 0.67, and debt-to-equity 0.33. Enterprise value is C$35,113,000.00 with an EV/Sales multiple of 1.63, indicating modest enterprise backing relative to revenue per share of 0.06.
Technical picture and volume drivers for TGOD.TO stock
Price sits below the 50-day average of C$0.24 and below the 200-day average of C$0.31, which signals longer-term weakness. Volatility indicators show ATR C$0.05 and Keltner channel middle at C$0.17. The surge in volume and a big gap between open (C$0.26) and close levels suggest short-term momentum traders dominate the pre-market session.
Meyka grade and TGOD.TO stock forecast
Meyka AI rates TGOD.TO with a score out of 100: 62.77 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a short-term level of C$0.17, matching the current price and implying 0.00% near-term change from C$0.17. Forecasts are model-based projections and not guarantees.
Price targets, scenarios and analyst-style outlook
We outline three plausible scenarios for TGOD.TO stock on the TSX in CAD terms. Bear case target: C$0.10 (implied downside -41.18%). Base case target: C$0.17 (implied 0.00%). Bull case target: C$0.40 (implied upside +135.29%). These targets reflect balance between thin liquidity, negative earnings, and organic cannabis demand recovery.
Risks, catalysts and sector context for TGOD.TO stock
Key risks include continued negative EPS, stretched working capital (working capital -C$21,997,000.00), and low cash per share (C$0.03). Catalysts that could lift the stock include improved gross margins, stronger retail distribution, or a corporate update on operations. The company sits in the Healthcare sector and the drug manufacturers industry. Healthcare sector YTD performance is weaker, which adds macro pressure to TGOD.TO stock.
Final Thoughts
TGOD.TO stock is the TSX’s clear pre-market leader by volume on 31 Mar 2026, trading at C$0.17 with 19,704,275 shares moved. The surge in activity shows market attention but not a clean technical setup: price remains below the 50-day (C$0.24) and 200-day (C$0.31) averages and the company posts negative EPS -0.23 and thin cash per share C$0.03. Meyka AI’s forecast model projects C$0.17 in the near term, implying 0.00% change versus the current price. Our scenario frame lists a conservative bear target of C$0.10 (-41.18%) and a bullish target of C$0.40 (+135.29%), driven by potential operational improvements or renewed retail demand. Given the tight liquidity profile, below-average book coverage, and sector headwinds, we view TGOD.TO stock as high risk for traders and appropriate for speculative positions only. For deeper context and live tools, see the company site and our stock page at Meyka AI for real-time updates and data-driven market analysis. Forecasts are model-based projections and not guarantees.
FAQs
What is the current price and volume for TGOD.TO stock?
TGOD.TO stock trades at C$0.17 pre-market on 31 Mar 2026 with 19,704,275 shares traded so far. Average volume is 1,585,835, so today’s flow is roughly 12.43x the average.
What are Meyka AI’s ratings and forecast for TGOD.TO?
Meyka AI rates TGOD.TO 62.77 out of 100 (Grade B, Suggestion: HOLD). The short-term model projects C$0.17, equal to the current price. These outputs are model-based and not guarantees.
What main risks affect The Green Organic Dutchman (TGOD.TO stock)?
Primary risks are negative earnings (EPS -0.23), low cash per share (C$0.03), weak liquidity, and sector headwinds in healthcare drug manufacturers. Operational updates or distribution gains would be required to reduce risk.
What price targets should traders consider for TGOD.TO stock?
We outline three scenarios: Bear C$0.10 (-41.18%), Base C$0.17 (0.00%), Bull C$0.40 (+135.29%). Use position sizing and risk controls; targets are illustrative, not investment advice.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)